SS18-SSX drives CREB activation in synovial sarcoma
Magdalene Cyra(University Hospital Münster), Wolfgang Hartmann(University Hospital Münster)
Cited by 9
Related Papers
PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups
|PLoS ONE|2015|228
SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia
|Nature Medicine|2016|185
EZH2 Inhibition in Ewing Sarcoma Upregulates GD2 Expression for Targeting with Gene-Modified T Cells
|Molecular Therapy|2019|126
SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma
|Oncogene|2013|95
Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomes
|Nature Communications|2019|72